IL6 and neoplasm: In contrast, iCAFs secrete pro-inflammatory cytokines (e.g., IL-6, C-X-C motif chemokine ligand 12 (CXCL12)) to fuel tumor growth, while ApCAFs modulate adaptive immunity through antigen presentation, thereby shaping therapeutic responses in HCC (211, 214, 215).